SCAI 2025 Announces its Late-Breaking and Featured Clinical Research Presentations
PUBLISHED:

The Society for Cardiovascular Angiography & Interventions has unveiled its late-breaking and featured clinical research sessions.

SCAI 2025 Scientific Sessions will be held from the 1st to 3rd May at Walter E. Washington Convention Center in Washington, DC. Access the full programme here.

 

Late Breaking Clinical Research

Friday 2nd May, 10:50 – 12:15pm (EDT)

  • Balloon-Assisted Modification of the Anterior Mitral Leaflet to Prevent Outflow Track Obstruction During Transeptal Transcatheter Mitral Valve Replacement – Presented by Dr Gennaro Giustino
  • Safety and Feasibility of the Supira System in High-Risk Percutaneous Coronary Interventions: 30-Day Results from the US SUPPORT I Early Feasibility Study (EFS) – Presented by Dr David Kandzari
  • The Look Inside in the Benefit of Physiology-Guided Revascularization: From Diagnostic Value to Prognostic Implication of Quantitative Flow Ratio (QFR) – Presented by Dr Hao-Yu Wang
  • Impact of Age on Procedural Timing for Asymptomatic Severe Aortic Stenosis: Results from the Early TAVR Trial – Presented by Dr Philippe Genereux
  • A Prospective Study of the Next Generation AVENTUS Thrombectomy System: Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism – Presented by Dr Jun Li
  • The PERFORMANCE II Trial: A Prospective Multicenter Single Arm Investigation of the Neuroguard IEP® 3-in-1 Carotid Stent System with Integrated Embolic Protection. Stent Durability and Patency at 2 years

 

Featured Clinical Research

Friday 2nd May, 10:50 – 12:15pm (EDT)

  • Antiplatelet Therapy and All-cause Mortality after Transcatheter Aortic Valve Replacement – Insights from the TRITAVI Registry – Presented by Dr Francesco Pelliccia
  • Incidence and Gender-Based Comparison of Prosthesis-Patient Mismatch (PPM) in patients undergoing transcatheter aortic valve implantation (TAVI) – Presented by Dr Karim Al-Azizi
  • Clinical, angiographic, and procedural features of patients likely to have MACE despite online QFR-guided PCI: Insights from FAVOR III China trial – Presented by Dr Hao-Yu Wang
  • Clinical Outcomes of Stented vs. Non-Stented Chronic Total Occlusion Patient – Presented by Dr M Chadi Alraies
  • Orthopedic Risks to Cardiac Catheterization Operators wearing traditional lead protection versus using novel lead-less solutions: Insights from the Prospective ERGO-CATH Study – Presented by Dr Ajar Kochar
  • Etiology, Management and Outcomes of Society for Cardiovascular Angiography and Interventions Stage B Cardiogenic Shock – Presented by Dr Saraschandra Vallabhajosyula
  • Percutaneous Coronary Intervention in Ambulatory Surgery Centers: Procedural Volume Trends and Outcomes in the Medicare Population – Presented by Ms Katerina Dangas

 

References

SCAI 2025 Scientific Sessions. 2025 Scientific Sessions. 2025. https://scai.confex.com/scai/2025/meetingapp.cgi/Home/0 (accessed 28 March 2025).

Share: